57:15

Perspectives from a Multidisciplinary Oncology Team on How to Reduce Racial Disparities

01:07:43

Part 5 - Molecular and Precision Medicine (MAP) Series

01:01:48

Part 3 - Molecular and Precision Medicine (MAP) Series

38:41

Part 2 - Molecular and Precision Medicine (MAP) Series

01:05:36

Part 1 - Molecular and Precision Medicine (MAP) Series

01:01:24

Part 4 - Molecular and Precision Medicine (MAP) Series

21:03

Preferentially Targeting the Malignant Hematopoietic Clone in Myeloproliferative Neoplasms (MPN)

48:14

Integrating Pathologic and Genomic Factors to Make Treatment Decisions in Patients with GI Cancers

01:38

Targeting SWI/SNF-Hippo Axis in Squamous Cancers

01:33

IDH Inhibition in Acute Myeloid Leukemia –Emergence of a New Therapeutic Era

01:41

Epigenetic Reversal of Chemotherapy Resistance in Cancers

04:21

Cross-resistance in Small Cell Lung Cancer

03:31

RET As a Target in Lung Cancer

00:29

Innovations in Cell Therapy

01:57

ctDNA, a Biomarker of Residual Disease and Tumor Response in Gastrointestinal Cancers

03:03

(Overview) Targeting Cell Death Pathways with Precision Using Functional Assays

03:15

(Overview) Molecular Tumor Board: Resistance to Checkpoint Inhibitors Part 2

03:38

(Overview) CAR-T Cell Therapy of Ovarian Cancer

00:55

(Overview) Microfluidics for the Characterization of Tumor-specific Extracellular Vesicles

02:28

(Overview) Beyond PARP1: Ribosylation as a Target for Cancer Therapy

02:49

(Overview) New Biomarkers in a Novel Antibody-drug Conjugate for Triple Negative Breast Cancer

07:35

(Overview) Molecular Tumor Board: Resistance to Checkpoint Inhibitors - Part 1

03:13

(Overview) Lin28B, a Promoter of Metastasis and Drug Resistance

05:08

(Overview) Clinical Application of Liquid Biopsies and Genotype directed Targeted...

04:34

(Overview) Melanoma: Clues to Improved Therapeutic Efficacy from Disease Pathogenesis

02:57

(Overview) Clinical Utility of Longitudinal Molecular Profiling for Management of ALK-Positive...

02:25

Targeting the ATR Kinase in Cancer Therapy

02:16

Intergenic Fusions in Advanced HR+ Breast Cancer

02:57

Assessing DNA Repair in Clinical Trials

04:19

Antibody Drug Conjugates for Triple Negative Breast Cancer: Targeting Positive in the Negative

02:48

PARP in Breast Cancer

04:07

Genomic and Functional Characterization of Patient Derived Xenograft Models of SCLC

04:36

PARP Inhibitor Resistance and Acquired Vulnerability in Ovarian Cancer

03:08

Is FGFR Inhibition an Effective Target in Gastrointestinal Tumors?

01:49

Developing Therapies for Ras-driven Cancers

41:46

Molecular Tumor Board

54:43

Epigenetic Mechanisms of Tumor Initiation and Evolution

46:59

Addressing Cancer Clonal Heterogeneity: Developing Personalized Neoantigen-Based Cancer Vaccines

26:02

Genomics of a Mitochondria-Rich Tumor

44:54

Developing Therapies for Transcriptionally Addicted Tumors

32:51

Dihydroorotate Dehydrogenase: An Unexpected Metabolic Vulnerability in Acute Myeloid Leukemia

39:50

FLT3 Inhibitors in the Therapy of Acute Myeloid Leukemia

51:22

T-Cell Therapy: Current Applications and Future Directions

33:37

Optimal MAPK Inhibition as a Key Component of Therapeutic Strategies for KRAS Mutant Cancers

25:37

Generation of Models of Human Hematologic Malignancies Using CRISPR Genome Engineering

35:06

Oncology Drug Development in the Era of Precision Medicine: FDA Perspective

18:07

Molecular Analysis of CTCs in Prostate Cancer

39:36

Alternative Lengthening of Telomeres Renders Cancer Cells Hypersensitive to ATR Inhibitors

15:48

Loss of SIRT6 Reactivates the Oncofetal Protein Lin28b to Drive Pancreatic Cancer

39:45

The “BRCA-Like” Phenotype in Cancer

16:14

The Lazarex-MGH Cancer Care Equity Program

42:01

Monitoring Cancer Through Circulating Tumor Cells

47:43

Emerging Therapies to Optimize MAP Kinase Blockade and Intercept Compensatory Signaling

39:10

The Changing Nature of Phase I Trials

43:09

Pathogenesis and Therapy of IDH-TET-Mutant Myeloid Malignancies

43:56

The Histone Deacetylase SIRT6: Linking Epigenetics to Cancer Metabolism

43:51

Molecular Profile of Acute Myeloid Leukemia (AML)

32:22

Improving the Treatment of Prostate Cancer

31:02

Exploiting Methylthioadenosine Phosphorylase Deficiency in Cancer

57:57

Advances in Molecular Screening NGS